Pharma Marketing Network

Medical journals may soon become the pharmaceutical industry's newest physician marketing partner. This article summarizes some of the pros and cons of FDA's Good Reprint Practices Guidance and presents preliminary results of a reader survey on the topic.

As everyone knows by now, Pfizer caved in to withering criticism from Congress and the Pharma BlogospereT and pulled the Jarvik Lipitor ads. 'Oh what a tangled web we weave, When first we practise to deceive!'

Welcome to the February, 2008 issue of Pharma Marketing News.

Vol. 7, No. 2: February 2008 - EXECUTIVE SUMMARY Welcome to this issue of Pharma Marketing News. Subscribe Now to...

According to an AP story, "Syndicated talk show host Montel Williams is being replaced by a younger version of himself. CBS Television Distribution announced...

I'd like to explore the connection between the current presidential campaign--including its caucuses and coffee shop interviews--with the direct-to-consumer (DTC) marketing of drugs like...

Click image to enlarge.Have you seen this new Crestor print ad from AstraZeneca? Crestor is one of the newer anti-cholesterol drugs that recently gained...

The event is the premier industry meeting place for senior level pharmaceutical executives looking to network with and learn from industry experts in the areas of legal, regulatory and compliance.

Maximize Value through Customer Service Excellence, Quality Control, Improved Process Management and Enhanced Technology Suppor

There seems to be a proliferation of "real" diseases that "primarily affect middle-aged women." That, for example, is how fibromyalgia is described (see "Drug...